Shots:
- The ANVISA has approved Uztok, a biosimilar version of Stelara (ustekinumab)
- Ustekinumab is a human interleukin-12 and -23 antagonist
- Uztok is indicated for Plaque psoriasis, Psoriatic arthritis, Crohn’s disease, and Ulcerative colitis
Ref: Gov.br | Image: SteinCares | Press Release
Related News: Celltrion Plans to File for Approval of Herzuma SC (Biosimilar, Herceptin) in Europe and Korea
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
